Condition: Graves Ophthalmopathy · Thyroid Associated Ophthalmopathy · Thyroid Associated Orbitopathy · Sponsor: Lund University
In an investigator initiated multicenter trial (Malmö, Odense, Århus) the investigators aim at evaluating activity of Graves´ophthalmopathy (GO) and progress to severe GO in patients with mild to moderate Graves´ ophthalmopathy treated with simvastatin or no treatment.
This description comes directly from the study's public registry record.
Tereza Planck, MD, PhD · +46-733873399 · tereza.planck@med.lu.se
Sabina Andersson, MD, PhD · sabina.andersson_geimer@med.lu.se
Always discuss trial participation with your own doctor first.
| Dpt. of Endocrinology, SUS Malmö | Malmö, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03131726